A novel five-antibody immunohistochemical test for subclassification of lung carcinoma. - Wikidata - wikimedia - TriplyDB

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

http://www.wikidata.org/entity/Q34980292

about

Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer Promising targets and current clinical trials in metastatic squamous cell lung cancer Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients Large cell carcinoma of the lung – a vanishing entity?Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients.EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance.The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung.Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist's Perspective A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.RNA-Seq quantification of the human small airway epithelium transcriptome The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer A transcriptional network signature characterizes lung cancer subtypes Emerging understanding of multiscale tumor heterogeneity FXYD3: A Promising Biomarker for Urothelial Carcinoma.Isolation of cancer stem like cells from human adenosquamous carcinoma of the lung supports a monoclonal origin from a multipotential tissue stem cell.From the bench to bedside: biological and methodology considerations for the future of companion diagnostics in nonsmall cell lung cancer.MicroRNA-dependent regulation of transcription in non-small cell lung cancer.Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung.L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.Targeting the intracellular MUC1 C-terminal domain inhibits proliferation and estrogen receptor transcriptional activity in lung adenocarcinoma cells.Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue.SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.Molecular Classification of Lobular Carcinoma of the Breast Personalized medicine for lung cancer: new challenges for pathology.Hidden treasures in "ancient" microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue.Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.Histology matters: individualizing treatment in non-small cell lung cancer.Clustering-Based Method for Developing a Genomic Copy Number Alteration Signature for Predicting the Metastatic Potential of Prostate Cancer.Immunohistochemical profiling of ALK fusion gene-positive adenocarcinomas of the lung.Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.The classification of lung carcinoma: time to change the morphology-based approach?Informative three-dimensional survey of cell/tissue architectures in thick paraffin sections by simple low-vacuum scanning electron microscopy.Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay

P2860

Q24600990-5AE26054-B15D-4D47-A37C-98B18AB0DCAD Q28083663-1699F1D8-369B-41B1-B7E0-3E7B4B0DFD54 Q28382908-17D8A099-B0AC-4C3E-9892-5002891207FB Q29040247-7F48DA77-D49A-442D-9B5E-82B382871F74 Q30432789-E729D307-18C2-42F7-A66F-BBCE020524AE Q30664830-16226A6A-574C-48F2-B0CF-57C9DDF07CF7 Q33566693-28A2A553-6173-496D-84D2-560B61F47B12 Q33680827-74BA4368-ADD6-4170-B8AA-67973B1FE621 Q33906921-22CA58E8-FF9E-4E17-B20F-562CD2333C2E Q33974932-FFB87BA9-4D03-4D27-B1BD-E48A86960BC8 Q34178271-A1C18B04-398F-4004-9056-5F46D06D79B7 Q34262527-80E04E96-78DB-4338-ABB8-7B36E51D4D00 Q34361505-A1099790-328E-404D-B840-0C9877B251A0 Q34472310-72644784-91EE-4FDB-98BB-885648BE5BC6 Q34730000-2F761CED-1CA8-4B48-8DE8-2A81C6420D67 Q34788904-243FC950-FF04-411E-97D7-C52934C1309B Q35063687-C47464F2-10BB-4A88-AC5E-6E3CD381C8BB Q35117568-0403C9B4-218C-4115-B12D-2CD0AF4E300A Q35119983-0F55342F-F260-421F-9543-0E846358AD40 Q35287629-43B1B5D8-8ECE-4F0C-8279-2272C0E4FE0C Q35416836-71ABD05B-5FD0-47FC-BCDC-E72F3BDD51F0 Q35541712-9B4DEE5A-E4CA-4AF1-850E-F0C256E91832 Q35561695-C49B8BDB-1D97-4812-BCD2-3C6F6300C2E2 Q36031798-4EC4FC19-C8F1-48A9-ACAE-DBFAB5A44DCA Q36829459-19209717-EB17-49E4-A8E2-F04837AECDB8 Q37031799-77B24BDA-EDF1-467B-A260-70548D381AC1 Q37680006-6687EB41-A24F-48DE-B1BD-2B8D86BB6E10 Q37708047-081671DB-6417-4767-BFFA-6ECA538508CD Q37932029-2DC976B7-85A5-46B4-B26D-BC8EF9510C9F Q38471484-F8F947F9-E4E6-4D80-A93E-61AFE0C3EFE4 Q41414717-2D3BC8DC-565F-4981-8246-3F710F00E399 Q42994677-118C41EC-E2EF-4C35-836A-7C58D8039000 Q43022331-C37AE6DC-7A19-4CAC-A229-6BA6060B4FBD Q43983107-A608BD8A-F82D-43E4-BD8F-57C2F13483A2 Q51563657-75632EF7-7C82-4A3D-9D36-A3A7EAB9CC97 Q51698466-5BB7C2BF-F5DC-43A3-AF23-4471A9DA3D59 Q55020539-E18576BB-41DA-4AC0-9F52-87925E33D275 Q56795277-BEF52EFC-742A-4A91-BEA2-C73F8FBE39B4

P2860

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

http://www.wikidata.org/entity/Q34980292

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@ast

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@en

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@nl

type

label

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@ast

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@en

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@nl

prefLabel

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@ast

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@en

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@nl

P1433

Q34980292-627F5FDB-E83D-4BED-B821-DCFCFC90FC36

P1476

Q34980292-697155A5-0B20-48BA-8A86-15C062DE61C3

P2093

Q34980292-291FC5A6-2657-4E00-A5A2-E5478B28100D

Q34980292-3A4B66E7-A0CB-46B4-ADD4-0A2CC59C8F4C

Q34980292-4CA2BEF7-2A6E-4627-85A9-618DA2E9AB45

Q34980292-889E812C-0040-4C00-8134-74AF0A6E8A80

Q34980292-A06960A7-98BB-4937-9D07-55B4199210AF

Q34980292-AAE1834B-E433-489F-A5FA-FCD81935B6B4

Q34980292-ABEE4DB8-D32A-4F25-A974-025E24D04E7B

Q34980292-FD1F906F-3AEF-41EC-AA73-7063E83C250F

P2860

Q34980292-168BD858-DD00-4F78-A1D2-FC3CB3F1E80A

Q34980292-173AC2AB-4B72-4DC0-83C4-11274BEE5D3C

Q34980292-2039DC42-22C7-4A0B-9A17-B3CE9CC2E081

Q34980292-2ECBA5C3-AAEB-4C40-8BEC-64E07DC13CF5

Q34980292-3CB06A9C-9823-4488-9D55-E11DF4A2BA35

Q34980292-3E53685A-3296-4A21-A437-6047C68AF737

Q34980292-413050E5-D841-47A3-A86E-8DF230AB884E

Q34980292-485F92E6-F432-41AB-BDDD-67FD26BD364F

Q34980292-5843A31C-4D6C-40FB-8838-781808737486

Q34980292-5A457C70-E36B-4195-A8CC-13721EB3EAD1

P2888

Q34980292-45A3B7A5-95C4-49B8-BBA9-3A7267E966AB

P304

Q34980292-FC50D2CD-6973-461A-8C94-79A0407E90B3

P31

Q34980292-6816CB54-60A0-43D2-B13F-F2CFA0F6487E

P356

Q34980292-4A04AFB5-4E4C-4B50-A9D6-3152A3E79C2C

P433

Q34980292-5BC85B2F-EAE5-4523-9CFC-503D31FFA2C9

P478

Q34980292-F04B91A7-A6F4-42AE-B9B9-6A81C5FD63B6

P50

Q34980292-89EE8B48-10F0-407D-BB92-DC8ECD66497E

P577

Q34980292-4D44AF19-8149-4C44-997F-402D490214E2

P5875

Q34980292-82494B16-976E-47C6-AEC2-635844CB031A

P6179

Q34980292-B8886BB0-AF8A-4CC7-B250-5A3049C7B6D9

P698

Q34980292-36C0C761-91B9-4DDF-9425-2B74E97FA9A7

P921

Q34980292-0169207E-9C55-4079-A906-AE2E91965E9A

Q34980292-7D0194BA-AF53-488E-8038-D5CAB2C41C3A

P356

MODPATHOL.2009.60

P1433

Modern Pathology

P1476

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

@en

P2093

Alex Soltermann

http://www.w3.org/2001/XMLSchema#string

Brian Z Ring

http://www.w3.org/2001/XMLSchema#string

Francisco Robert

http://www.w3.org/2001/XMLSchema#string

Marshall T Schreeder

http://www.w3.org/2001/XMLSchema#string

Robert S Seitz

http://www.w3.org/2001/XMLSchema#string

Rodney A Beck

http://www.w3.org/2001/XMLSchema#string

Stefanie Arbogast

http://www.w3.org/2001/XMLSchema#string

William J Shasteen

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer

New molecularly targeted therapies for lung cancer

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

The 2004 World Health Organization classification of lung tumors

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer

Erlotinib in previously treated non-small-cell lung cancer

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Diversity of gene expression in adenocarcinoma of the lung

P2888

modpathol.2009.60

P304

1032-1043

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2009.60

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Douglas T. Ross

P577

2009-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24416007

http://www.w3.org/2001/XMLSchema#string

P6179

1045629518

http://www.w3.org/2001/XMLSchema#string

P698

19430419

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry